{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:42:38Z","timestamp":1789663358870,"version":"4.0.1"},"reference-count":21,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2017,3,12]],"date-time":"2017-03-12T00:00:00Z","timestamp":1489276800000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 HL107152"],"award-info":[{"award-number":["P01 HL107152"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P40OD010431"],"award-info":[{"award-number":["P40OD010431"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 A1074844"],"award-info":[{"award-number":["R21 A1074844"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AI068642"],"award-info":[{"award-number":["U01 AI068642"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AI090959"],"award-info":[{"award-number":["U19 AI090959"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Xenotransplantation"],"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Inflammation is known to preclude tolerance after transplantation. We have previously shown that systemic inflammation in xenograft recipients (<jats:styled-content style=\"fixed-case\">SIXR<\/jats:styled-content>) precedes activation of coagulation in the absence of T cell responses. Accordingly, <jats:styled-content style=\"fixed-case\">SIXR<\/jats:styled-content> may amplify innate and adaptive immune responses against xenografts after pig\u2010to\u2010primate xenotransplantation, even with efficient immunosuppressive therapy. We evaluated the impact of anti\u2010inflammatory agents on pro\u2010inflammatory cytokines and chemokines in pig artery patch and heart xenograft recipients. Baboons received an artery patch (Group1, n=8) or heart (Group2, n=4) from genetically engineered pigs. All baboons received lymphodepletion with thymoglobulin (<jats:styled-content style=\"fixed-case\">ATG<\/jats:styled-content>) and costimulation blockade\u2010based immunosuppression (anti\u2010<jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>40 and\/or <jats:styled-content style=\"fixed-case\">CTLA<\/jats:styled-content>4Ig). In Group1, baboons received either (i) no anti\u2010inflammatory agents (n=2), (ii) cobra venom factor (<jats:styled-content style=\"fixed-case\">CVF<\/jats:styled-content>, n=2), (iii) \u03b11\u2010antitrypsin (<jats:styled-content style=\"fixed-case\">AAT<\/jats:styled-content>, n=2), or (iv) interleukin (<jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>)\u20106 receptor antagonist (<jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20106<jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>, n=2). In Group2, all baboon received corticosteroids, either without (n=2) or with (n=2) <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20106<jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>. Serum <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010\u03b3, <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>\u2010\u03b1, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20101\u03b2, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201017, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20106, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20108, <jats:styled-content style=\"fixed-case\">MCP<\/jats:styled-content>\u20101, and <jats:styled-content style=\"fixed-case\">sCD<\/jats:styled-content>40L levels were measured by Luminex. Fibrinogen, D\u2010dimers, and C\u2010reactive protein (C\u2010<jats:styled-content style=\"fixed-case\">RP<\/jats:styled-content>) were also measured. Recipient baboon T cell proliferation was evaluated by mixed lymphocyte reaction (<jats:styled-content style=\"fixed-case\">MLR<\/jats:styled-content>) before and after transplantation. Pig and baboon tissue factor (<jats:styled-content style=\"fixed-case\">TF<\/jats:styled-content>) <jats:styled-content style=\"fixed-case\">mRNA<\/jats:styled-content> levels in heart xenografts were measured by <jats:styled-content style=\"fixed-case\">RT<\/jats:styled-content>\u2010PCR. In no recipient was a marked increase in T cell response to pig cells observed after transplantation. In Groups 1 and 2, post\u2010transplantation levels of <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010\u03b3, <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>\u2010\u03b1, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20101\u03b2, and <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201017 remained comparable to or lower than pre\u2010transplant levels, except in one heart recipient that succumbed to <jats:styled-content style=\"fixed-case\">CMV<\/jats:styled-content> infection. In Group1, when no anti\u2010inflammatory agent was administered, post\u2010transplant levels of <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20106, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20108, and <jats:styled-content style=\"fixed-case\">MCP<\/jats:styled-content>\u20101 were elevated. After <jats:styled-content style=\"fixed-case\">CVF<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> IL<\/jats:styled-content>\u20106, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20108, and <jats:styled-content style=\"fixed-case\">MCP<\/jats:styled-content>\u20101 remained low. After <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20106<jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> IL<\/jats:styled-content>\u20106 and <jats:styled-content style=\"fixed-case\">MCP<\/jats:styled-content>\u20101 were elevated. After <jats:styled-content style=\"fixed-case\">AAT<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> IL<\/jats:styled-content>\u20108 was elevated. <jats:styled-content style=\"fixed-case\">sCD<\/jats:styled-content>40L became elevated intermittently in most recipients irrespective of the administered anti\u2010inflammatory agent. In Group2, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20106 was transiently elevated, particularly after <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20106<jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> administration. <jats:styled-content style=\"fixed-case\">MCP<\/jats:styled-content>\u20101 gradually increased by 2\u00a0months in Group2 recipients. <jats:styled-content style=\"fixed-case\">sCD<\/jats:styled-content>40L generally remained low except in one recipient. In Group1 and Group2 recipients, C\u2010<jats:styled-content style=\"fixed-case\">RP<\/jats:styled-content> levels were elevated except after <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20106<jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> administration, while D\u2010dimers were elevated regardless of administration of anti\u2010inflammatory agent. In Group2, pig <jats:styled-content style=\"fixed-case\">TF mRNA<\/jats:styled-content> levels were increased in heart xenografts compared to naive pig hearts, irrespective of <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20106 receptor antagonist administration. Additionally, baboon <jats:styled-content style=\"fixed-case\">TF mRNA<\/jats:styled-content> levels were detectable in heart xenografts, but not in naive pig hearts. Some pro\u2010inflammatory cytokines and chemokines are elevated in xenograft recipients, even with efficient T cell\u2010directed immunosuppressive therapy. Persistent elevation of D\u2010dimers, and individual cytokines and chemokines suggest a continuous inflammatory response, despite administration of anti\u2010inflammatory agents. Systemic administration of combined anti\u2010inflammatory agents as well as complement regulation may be essential to prevent <jats:styled-content style=\"fixed-case\">SIXR<\/jats:styled-content> after xenotransplantation.<\/jats:p>","DOI":"10.1111\/xen.12296","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T15:18:50Z","timestamp":1489504730000},"source":"Crossref","is-referenced-by-count":48,"title":["Therapeutic regulation of systemic inflammation in xenograft recipients"],"prefix":"10.1111","volume":"24","author":[{"given":"Hayato","family":"Iwase","sequence":"first","affiliation":[{"name":"Thomas E. Starzl Transplantation Institute University of Pittsburgh  Pittsburgh PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[{"name":"Thomas E. Starzl Transplantation Institute University of Pittsburgh  Pittsburgh PA USA"},{"name":"Department of General Surgery First Hospital of Shanxi Medical University  Taiyuan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[{"name":"Thomas E. Starzl Transplantation Institute University of Pittsburgh  Pittsburgh PA USA"},{"name":"Center for Kidney Transplantation Second Affiliated Hospital of the University of South China  Hengyang Hunan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongquiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Thomas E. Starzl Transplantation Institute University of Pittsburgh  Pittsburgh PA USA"},{"name":"Department of General Surgery Second Xiangya Hospital of the Central South University  Changsha Hunan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingsi","family":"Gao","sequence":"additional","affiliation":[{"name":"Thomas E. Starzl Transplantation Institute University of Pittsburgh  Pittsburgh PA USA"},{"name":"Center for Kidney Transplantation Second Affiliated Hospital of the University of South China  Hengyang Hunan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Hara","sequence":"additional","affiliation":[{"name":"Thomas E. Starzl Transplantation Institute University of Pittsburgh  Pittsburgh PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wijkstrom","sequence":"additional","affiliation":[{"name":"Thomas E. Starzl Transplantation Institute University of Pittsburgh  Pittsburgh PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Long","sequence":"additional","affiliation":[{"name":"Thomas E. Starzl Transplantation Institute University of Pittsburgh  Pittsburgh PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Saari","sequence":"additional","affiliation":[{"name":"Thomas E. Starzl Transplantation Institute University of Pittsburgh  Pittsburgh PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ayares","sequence":"additional","affiliation":[{"name":"Revivicor  Blacksburg VA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8899-9431","authenticated-orcid":false,"given":"David K. C.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Thomas E. Starzl Transplantation Institute University of Pittsburgh  Pittsburgh PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed B.","family":"Ezzelarab","sequence":"additional","affiliation":[{"name":"Thomas E. Starzl Transplantation Institute University of Pittsburgh  Pittsburgh PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,3,12]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3215"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113260"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2011.04323.x"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.2741\/1780"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.581918"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.532259"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/xen.12133"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/xen.12182"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e318199c34f"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2010.03147.x"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/xen.12176"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199711150-00005"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12723"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3089.2012.00711.x"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000042"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/xen.12167"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1078942"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.4635"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-011-0251-2"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2005.04.052"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.9.3595"}],"container-title":["Xenotransplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fxen.12296","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/xen.12296","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T11:33:36Z","timestamp":1696160016000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/xen.12296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["10.1111\/xen.12296"],"URL":"https:\/\/doi.org\/10.1111\/xen.12296","archive":["Portico"],"relation":{},"ISSN":["0908-665X","1399-3089"],"issn-type":[{"value":"0908-665X","type":"print"},{"value":"1399-3089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3]]},"article-number":"e12296"}}